S.R. Schill & Associates’s iShares US Pharmaceuticals ETF IHE Stock Holding History

S.R. Schill & Associates’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-19,311	Closed	-$990K	–	78
2020 Q2	$990K	Sell	19,311 -9,618	-33%	-$484K	0.58%	26
2020 Q1	$1.3M	Buy	+28,929	New	+$1.46M	0.87%	19

Other funds holding IHE

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

S.R. Schill & Associates's IHE Position: Q3 2020 in Review

S.R. Schill & Associates sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2020, closing a stake of 19,311 shares — an estimated $990K sold.

S.R. Schill & Associates first reported a position in IHE in Q1 2020 and held it in 2 quarters. The position peaked at $1.3M in Q1 2020. 94 funds tracked by Wall St. Rank hold IHE as of Q3 2020.

S.R. Schill & Associates reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
S.R. Schill & Associates sold 19,311 iShares US Pharmaceuticals ETF shares in Q3 2020, an estimated $990K.
S.R. Schill & Associates first reported a position in iShares US Pharmaceuticals ETF in Q1 2020 and held it in 2 quarters.
S.R. Schill & Associates's iShares US Pharmaceuticals ETF position peaked at $1.3M in Q1 2020.
94 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2020.

Based on S.R. Schill & Associates's 13F filing for Q3 2020, filed 18 Nov 2020.